UnitedHealth (UNH) Stock Raises Dividend 5% for 17th Straight Year

TLDR

• UnitedHealth raised its quarterly dividend 5% to $2.32 per share, its 17th consecutive annual increase.
• The dividend will be paid on June 23, 2026, to shareholders of record as of June 15.
• All current board directors were re-elected at the 2026 annual meeting.
• Bernstein SocGen raised its UNH price target to $492, maintaining an Outperform rating.
• Wall Street holds a Moderate Buy consensus, with an average price target of $399.09 — about 5.86% above current levels.

UnitedHealth Group lifted its quarterly dividend by 5% to $2.32 per share following its 2026 annual shareholder meeting. The stock was trading at $377.92 at the time of the announcement.

UnitedHealth Group Incorporated, UNH

The increase marks the company’s 17th straight year of raising its dividend — a streak that spans market crashes, a pandemic, and now a turbulent operational stretch inside the company itself.

UNH has had a rough ride lately. The company has been dealing with rising medical costs, pressure in its Medicare Advantage business, and internal reshaping at Optum. Investor confidence took a hit following membership losses and weaker-than-expected profits.

So why raise the dividend now? Management is sending a message — that cash flow is improving and the worst may be behind them.

The payout goes to shareholders of record on June 15, 2026, with payment on June 23, 2026.

At the annual meeting, shareholders re-elected all current directors, including board members Charles Baker, Timothy Flynn, Stephen Hemsley, and Scott Gottlieb, among others.

Shareholders also approved the company’s executive compensation package and ratified Deloitte & Touche as the independent auditor. A proposal to require an independent Board Chair was voted down.

What Analysts Are Saying

Bernstein SocGen Group recently raised its price target on UNH from $444 to $492, keeping its Outperform rating. The upgrade was driven by an improved earnings per share outlook tied to a recovery in Medicare Advantage and higher target multiples.

Wall Street’s overall view sits at a Moderate Buy, based on 18 Buy ratings, four Holds, and one Sell.

The average price target of $399.09 implies about 5.86% upside from current levels. InvestingPro data suggests the stock is currently undervalued relative to its Fair Value.

What’s Changing Inside UNH

UnitedHealth has been cutting costs and tightening up operations across the board. One of the more notable moves was inside Optum Rx, where the company introduced a new transparent pharmacy benefit manager model. The new structure uses fee-based pricing and eliminates spread pricing — a move aimed at improving clarity and affordability.

On the headwind side, the Trump administration announced a temporary halt on Medicare enrollments for new home healthcare and hospice providers, citing fraud concerns. That nationwide moratorium adds another layer of complexity for the company’s Medicare-related business.

UNH has maintained dividend payments for 34 consecutive years. The company carries a current dividend yield of approximately 2.34% based on the recent trading price.

The next key data points for investors will be the June 15 record date and June 23 payment date for the newly declared dividend.

The post UnitedHealth (UNH) Stock Raises Dividend 5% for 17th Straight Year appeared first on CoinCentral.